nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—Lisinopril—systemic scleroderma	0.137	0.267	CbGbCtD
Amsacrine—ABCB1—Captopril—systemic scleroderma	0.102	0.2	CbGbCtD
Amsacrine—CYP2D6—Captopril—systemic scleroderma	0.0965	0.188	CbGbCtD
Amsacrine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0807	0.157	CbGbCtD
Amsacrine—ABCB1—Prednisone—systemic scleroderma	0.0645	0.126	CbGbCtD
Amsacrine—ABCB1—Methotrexate—systemic scleroderma	0.0324	0.063	CbGbCtD
Amsacrine—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.00133	1	CbGdCrCtD
Amsacrine—Affect lability—Prednisone—systemic scleroderma	0.000751	0.00155	CcSEcCtD
Amsacrine—Vomiting—Pentoxifylline—systemic scleroderma	0.000748	0.00154	CcSEcCtD
Amsacrine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000744	0.00153	CcSEcCtD
Amsacrine—Rash—Pentoxifylline—systemic scleroderma	0.000742	0.00153	CcSEcCtD
Amsacrine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000741	0.00153	CcSEcCtD
Amsacrine—Headache—Pentoxifylline—systemic scleroderma	0.000737	0.00152	CcSEcCtD
Amsacrine—Feeling abnormal—Captopril—systemic scleroderma	0.000735	0.00151	CcSEcCtD
Amsacrine—Infection—Leflunomide—systemic scleroderma	0.00073	0.0015	CcSEcCtD
Amsacrine—Vision blurred—Lisinopril—systemic scleroderma	0.000729	0.0015	CcSEcCtD
Amsacrine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000729	0.0015	CcSEcCtD
Amsacrine—Asthenia—Mometasone—systemic scleroderma	0.000728	0.0015	CcSEcCtD
Amsacrine—Hypotension—Azathioprine—systemic scleroderma	0.000727	0.0015	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000726	0.0015	CcSEcCtD
Amsacrine—Mood swings—Prednisone—systemic scleroderma	0.000723	0.00149	CcSEcCtD
Amsacrine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000723	0.00149	CcSEcCtD
Amsacrine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00072	0.00148	CcSEcCtD
Amsacrine—Tachycardia—Leflunomide—systemic scleroderma	0.000717	0.00148	CcSEcCtD
Amsacrine—Anaemia—Lisinopril—systemic scleroderma	0.000715	0.00147	CcSEcCtD
Amsacrine—Skin disorder—Leflunomide—systemic scleroderma	0.000714	0.00147	CcSEcCtD
Amsacrine—Hepatic failure—Methotrexate—systemic scleroderma	0.00071	0.00146	CcSEcCtD
Amsacrine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000707	0.00146	CcSEcCtD
Amsacrine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000707	0.00146	CcSEcCtD
Amsacrine—Body temperature increased—Captopril—systemic scleroderma	0.000705	0.00145	CcSEcCtD
Amsacrine—Abdominal pain—Captopril—systemic scleroderma	0.000705	0.00145	CcSEcCtD
Amsacrine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00145	CcSEcCtD
Amsacrine—Anorexia—Leflunomide—systemic scleroderma	0.000701	0.00144	CcSEcCtD
Amsacrine—Nausea—Pentoxifylline—systemic scleroderma	0.000699	0.00144	CcSEcCtD
Amsacrine—Infection—Mycophenolic acid—systemic scleroderma	0.000697	0.00144	CcSEcCtD
Amsacrine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00143	CcSEcCtD
Amsacrine—Diarrhoea—Mometasone—systemic scleroderma	0.000695	0.00143	CcSEcCtD
Amsacrine—Leukopenia—Lisinopril—systemic scleroderma	0.000693	0.00143	CcSEcCtD
Amsacrine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000688	0.00142	CcSEcCtD
Amsacrine—Hypotension—Leflunomide—systemic scleroderma	0.000687	0.00142	CcSEcCtD
Amsacrine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000687	0.00141	CcSEcCtD
Amsacrine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000684	0.00141	CcSEcCtD
Amsacrine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00141	CcSEcCtD
Amsacrine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000681	0.0014	CcSEcCtD
Amsacrine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000678	0.0014	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000672	0.00138	CcSEcCtD
Amsacrine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000668	0.00138	CcSEcCtD
Amsacrine—Paraesthesia—Leflunomide—systemic scleroderma	0.00066	0.00136	CcSEcCtD
Amsacrine—Dyspnoea—Leflunomide—systemic scleroderma	0.000655	0.00135	CcSEcCtD
Amsacrine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000655	0.00135	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000654	0.00135	CcSEcCtD
Amsacrine—Lethargy—Methotrexate—systemic scleroderma	0.000651	0.00134	CcSEcCtD
Amsacrine—Vomiting—Mometasone—systemic scleroderma	0.000646	0.00133	CcSEcCtD
Amsacrine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000641	0.00132	CcSEcCtD
Amsacrine—Rash—Mometasone—systemic scleroderma	0.00064	0.00132	CcSEcCtD
Amsacrine—Asthenia—Captopril—systemic scleroderma	0.00064	0.00132	CcSEcCtD
Amsacrine—Dermatitis—Mometasone—systemic scleroderma	0.00064	0.00132	CcSEcCtD
Amsacrine—Decreased appetite—Leflunomide—systemic scleroderma	0.000639	0.00132	CcSEcCtD
Amsacrine—Confusional state—Lisinopril—systemic scleroderma	0.000637	0.00131	CcSEcCtD
Amsacrine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000636	0.00131	CcSEcCtD
Amsacrine—Headache—Mometasone—systemic scleroderma	0.000636	0.00131	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000635	0.00131	CcSEcCtD
Amsacrine—Fatigue—Leflunomide—systemic scleroderma	0.000634	0.00131	CcSEcCtD
Amsacrine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00063	0.0013	CcSEcCtD
Amsacrine—Pain—Leflunomide—systemic scleroderma	0.000629	0.0013	CcSEcCtD
Amsacrine—Infection—Lisinopril—systemic scleroderma	0.000627	0.00129	CcSEcCtD
Amsacrine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000627	0.00129	CcSEcCtD
Amsacrine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000625	0.00129	CcSEcCtD
Amsacrine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000618	0.00127	CcSEcCtD
Amsacrine—Tachycardia—Lisinopril—systemic scleroderma	0.000616	0.00127	CcSEcCtD
Amsacrine—Abdominal pain—Azathioprine—systemic scleroderma	0.000615	0.00127	CcSEcCtD
Amsacrine—Body temperature increased—Azathioprine—systemic scleroderma	0.000615	0.00127	CcSEcCtD
Amsacrine—Skin disorder—Lisinopril—systemic scleroderma	0.000613	0.00126	CcSEcCtD
Amsacrine—Diarrhoea—Captopril—systemic scleroderma	0.00061	0.00126	CcSEcCtD
Amsacrine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00061	0.00126	CcSEcCtD
Amsacrine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00125	CcSEcCtD
Amsacrine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000606	0.00125	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000605	0.00125	CcSEcCtD
Amsacrine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000605	0.00125	CcSEcCtD
Amsacrine—Mood swings—Methotrexate—systemic scleroderma	0.000604	0.00125	CcSEcCtD
Amsacrine—Nausea—Mometasone—systemic scleroderma	0.000603	0.00124	CcSEcCtD
Amsacrine—Anorexia—Lisinopril—systemic scleroderma	0.000602	0.00124	CcSEcCtD
Amsacrine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000601	0.00124	CcSEcCtD
Amsacrine—Weight increased—Prednisone—systemic scleroderma	0.0006	0.00124	CcSEcCtD
Amsacrine—Pain—Mycophenolic acid—systemic scleroderma	0.0006	0.00124	CcSEcCtD
Amsacrine—Weight decreased—Prednisone—systemic scleroderma	0.000597	0.00123	CcSEcCtD
Amsacrine—Hypotension—Lisinopril—systemic scleroderma	0.00059	0.00122	CcSEcCtD
Amsacrine—Dizziness—Captopril—systemic scleroderma	0.00059	0.00122	CcSEcCtD
Amsacrine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00121	CcSEcCtD
Amsacrine—Urticaria—Leflunomide—systemic scleroderma	0.000584	0.0012	CcSEcCtD
Amsacrine—Body temperature increased—Leflunomide—systemic scleroderma	0.000581	0.0012	CcSEcCtD
Amsacrine—Abdominal pain—Leflunomide—systemic scleroderma	0.000581	0.0012	CcSEcCtD
Amsacrine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000578	0.00119	CcSEcCtD
Amsacrine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000573	0.00118	CcSEcCtD
Amsacrine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000573	0.00118	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000573	0.00118	CcSEcCtD
Amsacrine—Paraesthesia—Lisinopril—systemic scleroderma	0.000567	0.00117	CcSEcCtD
Amsacrine—Vomiting—Captopril—systemic scleroderma	0.000567	0.00117	CcSEcCtD
Amsacrine—Dyspnoea—Lisinopril—systemic scleroderma	0.000563	0.00116	CcSEcCtD
Amsacrine—Rash—Captopril—systemic scleroderma	0.000562	0.00116	CcSEcCtD
Amsacrine—Dermatitis—Captopril—systemic scleroderma	0.000562	0.00116	CcSEcCtD
Amsacrine—Headache—Captopril—systemic scleroderma	0.000559	0.00115	CcSEcCtD
Amsacrine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000558	0.00115	CcSEcCtD
Amsacrine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000554	0.00114	CcSEcCtD
Amsacrine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000554	0.00114	CcSEcCtD
Amsacrine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00113	CcSEcCtD
Amsacrine—Decreased appetite—Lisinopril—systemic scleroderma	0.000549	0.00113	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000545	0.00112	CcSEcCtD
Amsacrine—Fatigue—Lisinopril—systemic scleroderma	0.000545	0.00112	CcSEcCtD
Amsacrine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00112	CcSEcCtD
Amsacrine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000542	0.00112	CcSEcCtD
Amsacrine—Pain—Lisinopril—systemic scleroderma	0.00054	0.00111	CcSEcCtD
Amsacrine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00111	CcSEcCtD
Amsacrine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00111	CcSEcCtD
Amsacrine—Bradycardia—Prednisone—systemic scleroderma	0.000537	0.00111	CcSEcCtD
Amsacrine—Diarrhoea—Azathioprine—systemic scleroderma	0.000533	0.0011	CcSEcCtD
Amsacrine—Haemoglobin—Prednisone—systemic scleroderma	0.000531	0.00109	CcSEcCtD
Amsacrine—Nausea—Captopril—systemic scleroderma	0.00053	0.00109	CcSEcCtD
Amsacrine—Haemorrhage—Prednisone—systemic scleroderma	0.000528	0.00109	CcSEcCtD
Amsacrine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000527	0.00109	CcSEcCtD
Amsacrine—Asthenia—Leflunomide—systemic scleroderma	0.000527	0.00109	CcSEcCtD
Amsacrine—Pancytopenia—Methotrexate—systemic scleroderma	0.000524	0.00108	CcSEcCtD
Amsacrine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00052	0.00107	CcSEcCtD
Amsacrine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000519	0.00107	CcSEcCtD
Amsacrine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00107	CcSEcCtD
Amsacrine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000516	0.00106	CcSEcCtD
Amsacrine—Dizziness—Azathioprine—systemic scleroderma	0.000515	0.00106	CcSEcCtD
Amsacrine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000503	0.00104	CcSEcCtD
Amsacrine—Diarrhoea—Leflunomide—systemic scleroderma	0.000503	0.00104	CcSEcCtD
Amsacrine—Urticaria—Lisinopril—systemic scleroderma	0.000502	0.00103	CcSEcCtD
Amsacrine—Abdominal pain—Lisinopril—systemic scleroderma	0.000499	0.00103	CcSEcCtD
Amsacrine—Body temperature increased—Lisinopril—systemic scleroderma	0.000499	0.00103	CcSEcCtD
Amsacrine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000497	0.00102	CcSEcCtD
Amsacrine—Vomiting—Azathioprine—systemic scleroderma	0.000495	0.00102	CcSEcCtD
Amsacrine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00102	CcSEcCtD
Amsacrine—Infestation NOS—Methotrexate—systemic scleroderma	0.000492	0.00101	CcSEcCtD
Amsacrine—Infestation—Methotrexate—systemic scleroderma	0.000492	0.00101	CcSEcCtD
Amsacrine—Rash—Azathioprine—systemic scleroderma	0.000491	0.00101	CcSEcCtD
Amsacrine—Dermatitis—Azathioprine—systemic scleroderma	0.00049	0.00101	CcSEcCtD
Amsacrine—Headache—Azathioprine—systemic scleroderma	0.000488	0.001	CcSEcCtD
Amsacrine—Dizziness—Leflunomide—systemic scleroderma	0.000486	0.001	CcSEcCtD
Amsacrine—Renal failure—Methotrexate—systemic scleroderma	0.000483	0.000996	CcSEcCtD
Amsacrine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000481	0.000991	CcSEcCtD
Amsacrine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00048	0.000989	CcSEcCtD
Amsacrine—Stomatitis—Methotrexate—systemic scleroderma	0.000479	0.000987	CcSEcCtD
Amsacrine—Angiopathy—Prednisone—systemic scleroderma	0.000479	0.000987	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000478	0.000984	CcSEcCtD
Amsacrine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000473	0.000975	CcSEcCtD
Amsacrine—Arrhythmia—Prednisone—systemic scleroderma	0.000472	0.000972	CcSEcCtD
Amsacrine—Haematuria—Methotrexate—systemic scleroderma	0.000469	0.000966	CcSEcCtD
Amsacrine—Vomiting—Leflunomide—systemic scleroderma	0.000467	0.000963	CcSEcCtD
Amsacrine—Alopecia—Prednisone—systemic scleroderma	0.000467	0.000961	CcSEcCtD
Amsacrine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000465	0.000959	CcSEcCtD
Amsacrine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000465	0.000958	CcSEcCtD
Amsacrine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000464	0.000956	CcSEcCtD
Amsacrine—Rash—Leflunomide—systemic scleroderma	0.000463	0.000955	CcSEcCtD
Amsacrine—Dermatitis—Leflunomide—systemic scleroderma	0.000463	0.000954	CcSEcCtD
Amsacrine—Mental disorder—Prednisone—systemic scleroderma	0.000463	0.000953	CcSEcCtD
Amsacrine—Nausea—Azathioprine—systemic scleroderma	0.000462	0.000953	CcSEcCtD
Amsacrine—Headache—Leflunomide—systemic scleroderma	0.00046	0.000949	CcSEcCtD
Amsacrine—Malnutrition—Prednisone—systemic scleroderma	0.00046	0.000947	CcSEcCtD
Amsacrine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000459	0.000945	CcSEcCtD
Amsacrine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00094	CcSEcCtD
Amsacrine—Asthenia—Lisinopril—systemic scleroderma	0.000453	0.000934	CcSEcCtD
Amsacrine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000932	CcSEcCtD
Amsacrine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000446	0.000919	CcSEcCtD
Amsacrine—Haemoglobin—Methotrexate—systemic scleroderma	0.000443	0.000914	CcSEcCtD
Amsacrine—Rash—Mycophenolic acid—systemic scleroderma	0.000442	0.000911	CcSEcCtD
Amsacrine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000442	0.00091	CcSEcCtD
Amsacrine—Hepatitis—Methotrexate—systemic scleroderma	0.000441	0.000909	CcSEcCtD
Amsacrine—Haemorrhage—Methotrexate—systemic scleroderma	0.000441	0.000909	CcSEcCtD
Amsacrine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00044	0.000906	CcSEcCtD
Amsacrine—Headache—Mycophenolic acid—systemic scleroderma	0.000439	0.000905	CcSEcCtD
Amsacrine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000901	CcSEcCtD
Amsacrine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000901	CcSEcCtD
Amsacrine—Nausea—Leflunomide—systemic scleroderma	0.000437	0.0009	CcSEcCtD
Amsacrine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000436	0.000898	CcSEcCtD
Amsacrine—Vision blurred—Prednisone—systemic scleroderma	0.000433	0.000893	CcSEcCtD
Amsacrine—Urethral disorder—Methotrexate—systemic scleroderma	0.000433	0.000891	CcSEcCtD
Amsacrine—Diarrhoea—Lisinopril—systemic scleroderma	0.000432	0.00089	CcSEcCtD
Amsacrine—Anaemia—Prednisone—systemic scleroderma	0.000425	0.000875	CcSEcCtD
Amsacrine—Dizziness—Lisinopril—systemic scleroderma	0.000418	0.000861	CcSEcCtD
Amsacrine—Nausea—Mycophenolic acid—systemic scleroderma	0.000416	0.000858	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000409	0.000844	CcSEcCtD
Amsacrine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00084	CcSEcCtD
Amsacrine—Vomiting—Lisinopril—systemic scleroderma	0.000402	0.000827	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—systemic scleroderma	0.0004	0.000825	CcSEcCtD
Amsacrine—Rash—Lisinopril—systemic scleroderma	0.000398	0.000821	CcSEcCtD
Amsacrine—Convulsion—Prednisone—systemic scleroderma	0.000398	0.000821	CcSEcCtD
Amsacrine—Dermatitis—Lisinopril—systemic scleroderma	0.000398	0.00082	CcSEcCtD
Amsacrine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000398	0.000819	CcSEcCtD
Amsacrine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000818	CcSEcCtD
Amsacrine—Headache—Lisinopril—systemic scleroderma	0.000396	0.000815	CcSEcCtD
Amsacrine—Alopecia—Methotrexate—systemic scleroderma	0.00039	0.000803	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000389	0.000801	CcSEcCtD
Amsacrine—Mental disorder—Methotrexate—systemic scleroderma	0.000387	0.000797	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—systemic scleroderma	0.000384	0.000792	CcSEcCtD
Amsacrine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000379	0.00078	CcSEcCtD
Amsacrine—Nausea—Lisinopril—systemic scleroderma	0.000375	0.000773	CcSEcCtD
Amsacrine—Infection—Prednisone—systemic scleroderma	0.000373	0.000768	CcSEcCtD
Amsacrine—Tachycardia—Prednisone—systemic scleroderma	0.000366	0.000754	CcSEcCtD
Amsacrine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000366	0.000754	CcSEcCtD
Amsacrine—Skin disorder—Prednisone—systemic scleroderma	0.000364	0.000751	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—systemic scleroderma	0.000362	0.000746	CcSEcCtD
Amsacrine—Anorexia—Prednisone—systemic scleroderma	0.000358	0.000737	CcSEcCtD
Amsacrine—Anaemia—Methotrexate—systemic scleroderma	0.000355	0.000732	CcSEcCtD
Amsacrine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000725	CcSEcCtD
Amsacrine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000719	CcSEcCtD
Amsacrine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000718	CcSEcCtD
Amsacrine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000714	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—systemic scleroderma	0.000344	0.000709	CcSEcCtD
Amsacrine—Paraesthesia—Prednisone—systemic scleroderma	0.000337	0.000694	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—systemic scleroderma	0.000333	0.000686	CcSEcCtD
Amsacrine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000677	CcSEcCtD
Amsacrine—Decreased appetite—Prednisone—systemic scleroderma	0.000326	0.000672	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000325	0.000669	CcSEcCtD
Amsacrine—Fatigue—Prednisone—systemic scleroderma	0.000323	0.000666	CcSEcCtD
Amsacrine—Confusional state—Methotrexate—systemic scleroderma	0.000316	0.000651	CcSEcCtD
Amsacrine—Infection—Methotrexate—systemic scleroderma	0.000311	0.000642	CcSEcCtD
Amsacrine—Feeling abnormal—Prednisone—systemic scleroderma	0.000309	0.000637	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000307	0.000632	CcSEcCtD
Amsacrine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000307	0.000632	CcSEcCtD
Amsacrine—Skin disorder—Methotrexate—systemic scleroderma	0.000304	0.000627	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—systemic scleroderma	0.000299	0.000616	CcSEcCtD
Amsacrine—Urticaria—Prednisone—systemic scleroderma	0.000298	0.000614	CcSEcCtD
Amsacrine—Abdominal pain—Prednisone—systemic scleroderma	0.000297	0.000611	CcSEcCtD
Amsacrine—Body temperature increased—Prednisone—systemic scleroderma	0.000297	0.000611	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—systemic scleroderma	0.000293	0.000604	CcSEcCtD
Amsacrine—Paraesthesia—Methotrexate—systemic scleroderma	0.000281	0.00058	CcSEcCtD
Amsacrine—Dyspnoea—Methotrexate—systemic scleroderma	0.000279	0.000576	CcSEcCtD
Amsacrine—Hypersensitivity—Prednisone—systemic scleroderma	0.000276	0.000569	CcSEcCtD
Amsacrine—Decreased appetite—Methotrexate—systemic scleroderma	0.000273	0.000562	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000271	0.000558	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—systemic scleroderma	0.00027	0.000557	CcSEcCtD
Amsacrine—Asthenia—Prednisone—systemic scleroderma	0.000269	0.000555	CcSEcCtD
Amsacrine—Pain—Methotrexate—systemic scleroderma	0.000268	0.000552	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000258	0.000532	CcSEcCtD
Amsacrine—Diarrhoea—Prednisone—systemic scleroderma	0.000257	0.000529	CcSEcCtD
Amsacrine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000256	0.000528	CcSEcCtD
Amsacrine—Urticaria—Methotrexate—systemic scleroderma	0.000249	0.000513	CcSEcCtD
Amsacrine—Dizziness—Prednisone—systemic scleroderma	0.000248	0.000511	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—systemic scleroderma	0.000248	0.000511	CcSEcCtD
Amsacrine—Abdominal pain—Methotrexate—systemic scleroderma	0.000248	0.000511	CcSEcCtD
Amsacrine—Vomiting—Prednisone—systemic scleroderma	0.000238	0.000491	CcSEcCtD
Amsacrine—Rash—Prednisone—systemic scleroderma	0.000237	0.000487	CcSEcCtD
Amsacrine—Dermatitis—Prednisone—systemic scleroderma	0.000236	0.000487	CcSEcCtD
Amsacrine—Headache—Prednisone—systemic scleroderma	0.000235	0.000484	CcSEcCtD
Amsacrine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000231	0.000476	CcSEcCtD
Amsacrine—Asthenia—Methotrexate—systemic scleroderma	0.000225	0.000463	CcSEcCtD
Amsacrine—Nausea—Prednisone—systemic scleroderma	0.000223	0.000459	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—systemic scleroderma	0.000214	0.000442	CcSEcCtD
Amsacrine—Dizziness—Methotrexate—systemic scleroderma	0.000207	0.000427	CcSEcCtD
Amsacrine—Vomiting—Methotrexate—systemic scleroderma	0.000199	0.000411	CcSEcCtD
Amsacrine—Rash—Methotrexate—systemic scleroderma	0.000198	0.000407	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—systemic scleroderma	0.000197	0.000407	CcSEcCtD
Amsacrine—Headache—Methotrexate—systemic scleroderma	0.000196	0.000405	CcSEcCtD
Amsacrine—Nausea—Methotrexate—systemic scleroderma	0.000186	0.000384	CcSEcCtD
